Formuepleje A/S’s Biogen BIIB Stock Holding History

Formuepleje A/S’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-113,070	Closed	-$32.8M	–	89
2018 Q2	$32.8M	Buy	113,070 +30,200	+36%	+$8.49M	3.47%	9
2018 Q1	$22.7M	Sell	82,870 -4,200	-5%	-$1.3M	2.67%	14
2017 Q4	$27.7M	Buy	87,070 +3,270	+4%	+$1.05M	2.84%	14
2017 Q3	$26.2M	Sell	83,800 -9,600	-10%	-$2.84M	2.88%	14
2017 Q2	$25.3M	Buy	93,400 +23,200	+33%	+$6.13M	2.64%	15
2017 Q1	$19.2M	Buy	70,200 +7,800	+13%	+$2.21M	2.29%	17
2016 Q4	$17.7M	Sell	62,400 -400	-0.6%	-$119K	2.33%	20
2016 Q3	$19.7M	Sell	62,800 -4,700	-7%	-$1.39M	2.66%	16
2016 Q2	$16.3M	Buy	+67,500	New	+$17.8M	2.23%	18

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Formuepleje A/S's BIIB Position: Q3 2018 in Review

Formuepleje A/S sold out of Biogen (BIIB) in Q3 2018, closing a stake of 113,070 shares — an estimated $32.8M sold.

Formuepleje A/S first reported a position in BIIB in Q2 2016 and held it in 9 quarters. The position peaked at $32.8M in Q2 2018. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Formuepleje A/S reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
Formuepleje A/S sold 113,070 Biogen shares in Q3 2018, an estimated $32.8M.
Formuepleje A/S first reported a position in Biogen in Q2 2016 and held it in 9 quarters.
Formuepleje A/S's Biogen position peaked at $32.8M in Q2 2018.
1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Formuepleje A/S's 13F filing for Q3 2018, filed 27 Aug 2026.